Jeong-Eun Bang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeong-Eun Bang has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Bo Mi Kim
Department of Chemical Engineering, Wonkwang University, Iksan-si 54538, Jeollabuk-do, Republic of Korea
2 shared publications - Ga-Hyun Kim
Department of Chemical Engineering, Wonkwang University, Iksan-si 54538, Jeollabuk-do, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 13 June 2026
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 32 (4) , 58
Synthesis and In Vitro Evaluation of a Novel Tyrosinase-Targeting Cyclic Peptide with Radical Scavenging Activity
- 13 June 2026
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 32 (4) , 58
Open AccessSynthesis and In Vitro Evaluation of a Novel Tyrosinase-Targeting Cyclic Peptide with Radical Scavenging Activity
- Open Access
- 12 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 126
Comparison of In Vitro Multiple Physiological Activities of Cys–Tyr–Gly–Ser–Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking
Peptide cyclization is a strategy to improve biological stability and functional activity, but direct comparison between linear and cyclic peptides with the same sequence is still limited. In this study, linear (L-CR5) and cyclic (C-CR5) forms were synthesized, and biological functions such as antioxidant, whitening, and anti-wrinkle activity were compared and evaluated. C-CR5 showed about 22.3 times of DPPH radical scavenging activity, which was significantly stronger than L-CR5, and tyrosinase inhibition increased rapidly in C-CR5 to reach inhibition of 95% or more, whereas L-CR5 showed only moderate activity in the same range (about 6.5 times). MMP-1 expression in the evaluation of anti-wrinkle activity did not show a decreasing trend in L-CR5 at all, while C-CR5 showed an anti-wrinkle effect, which was reduced by about 92.8% at 400 μg/mL. As a result of molecular docking analysis, C-CR5 exhibited lower MolDock scores than L-CR5 toward both tyrosinase and MMP-1, indicating a potentially higher binding affinity and improved binding stability. This is expected to be due to reduced structural flexibility and optimized residue directions (especially Tyr and Arg). These results indicate that peptide cyclization is an example of enhanced functional bioactivity of CYGSR and provides a positive case for the structure–activity relationship.
- 12 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 126
Open AccessComparison of In Vitro Multiple Physiological Activities of Cys–Tyr–Gly–Ser–Arg (CYGSR) Linear and Cyclic Peptides and Analysis Based on Molecular Docking
Peptide cyclization is a strategy to improve biological stability and functional activity, but direct comparison between linear and cyclic peptides with the same sequence is still limited. In this study, linear (L-CR5) and cyclic (C-CR5) forms were synthesized, and biological functions such as antioxidant, whitening, and anti-wrinkle activity were compared and evaluated. C-CR5 showed about 22.3 times of DPPH radical scavenging activity, which was significantly stronger than L-CR5, and tyrosinase inhibition increased rapidly in C-CR5 to reach inhibition of 95% or more, whereas L-CR5 showed only moderate activity in the same range (about 6.5 times). MMP-1 expression in the evaluation of anti-wrinkle activity did not show a decreasing trend in L-CR5 at all, while C-CR5 showed an anti-wrinkle effect, which was reduced by about 92.8% at 400 μg/mL. As a result of molecular docking analysis, C-CR5 exhibited lower MolDock scores than L-CR5 toward both tyrosinase and MMP-1, indicating a potentially higher binding affinity and improved binding stability. This is expected to be due to reduced structural flexibility and optimized residue directions (especially Tyr and Arg). These results indicate that peptide cyclization is an example of enhanced functional bioactivity of CYGSR and provides a positive case for the structure–activity relationship.